S. 1049 · 115th Congress
Opioid Addiction Risk Transparency Act
- Stage
- In committee
- Sponsor
- Maggie Hassan
- Introduced
- 2017-05-04
- Latest action
- 2017-05-04 · Introduced in Senate
Summary
Opioid Addiction Risk Transparency Act
This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.